Answers are grounded in this paper and cite their sources.
Introduction: Remote ischemic conditioning is a non-invasive, easy-to-administer procedure providing brief, reversible episodes of ischemia conferring global protection to remote tissue or organs. In this study, we performed a meta-analysis on the available studies on patients receiving thrombolysis and thrombectomy. Methods: PubMed, Cochrane, Embase, and ClinicalTrials.gov were searched for articles from inception to 10 September 2023. Data were analyzed using Cochrane RevMan Web. Odds ratio (OR), mean difference (MD), and 95% confidence intervals (CI) were combined via fixed-effect analysis. Results: Seven randomized controlled trials were included with a total of 927 patients. Remote ischemic conditioning could reduce the recurrence of ischemic stroke at endpoints (OR 0.84, [0.30, 2.29]) and improve the clinical outcome (modified Rankin Scale 0-2) at 90 days (OR 0.96 [0.67, 1.36]) but the results are not significantly different from the control group. Conclusions: Remote ischemic conditioning shows promise in reducing ischemic stroke recurrence and improving patients’ prognosis at 90 days.
No takes yet. Share an insight, caveat, or question.
Hernandez et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: